TrialCheck® - eviti® Integration Brings Clinical Trials to the Point of Care

Philadelphia, PA [March 3, 2011] –ITA Partners, Inc. (ITA) and the Coalition of Cancer Cooperative Groups (Coalition) today announced that they have reached an agreement in which ITA has acquired ownership of TrialCheck^® – the leading cancer clinical trial search engine – from the Coalition. The TrialCheck database will be merged into ITA’s oncology decision-support platform – eviti^® – which currently contains nearly 1,000 treatment guidelines for 120+ types of cancer; and TrialCheck will remain available to the public via the Coalition website www.CancerTrialsHelp.org through a licensing arrangement.

“In our quest to be the most comprehensive oncology decision-support resource, accessible by every oncologist, to treat every cancer patient; we are constantly evolving eviti. This acquisition and integration of the clinical trials database is the ideal next step in providing a holistic approach to oncology treatment options,” said Eduardo Beruff, chief executive officer and president of ITA.

As new health care laws will soon require payers to reimburse for clinical trials, the need arises to determine a trial’s appropriateness for each patient. The integration of the TrialCheck database into eviti, not only meets the need, but benefits all parties involved:

Patients receive assurance that their physician will identify and suggest appropriate clinical trials as part of their full range of treatment options;
Physicians have access to the latest nationally-recognized evidence-based treatment options, including clinical trials that may be beneficial for the patient;
Payers are assured that the options presented through eviti, including clinical trials, fit the patient’s diagnosis, and that they are reimbursing for appropriate care.

The Coalition and ITA share a common philosophy that physicians, patients and payers should consider clinical trials as a viable treatment option; and integrating the TrialCheck database into eviti brings clinical trial options to the forefront, giving physicians even more treatment options at the point of prescribing.

“Strategically, we knew all along that in order to make clinical trials part of the treatment paradigm, a tool as precise as TrialCheck would be most effective when integrated into the normal workflow of the medical practice – where the key interactions among patients, physicians and payers take place.” said Robert L. Comis, MD, president and chairman of the Coalition. “The match with eviti is a perfect fit. While ITA has identified trial searching and protocol navigation as essential components of its product offering, it has not yet developed such a tool. The match repositions TrialCheck to become an integral component of a larger evidence-based prescribing approach.”

About eviti

eviti is a unique platform that, in real time, aligns physician and payer priorities at the point of care to ensure the most appropriate, evidence-based oncology treatment is administered from the start. ITA’s independent, non-proprietary digital oncology treatment library is one of the most comprehensive of its kind. It comprises nearly 1,000 of the most appropriate, proven treatment options covering all modalities for 120+ cancer types compiled from the world’s leading sources. eviti’s treatment knowledge base and decision-support engine help oncologists select a treatment option that is both evidence-based and compliant with each patient’s insurance plan language at the moment of prescribing. This transparent approach streamlines workflow and reimbursement, reduces variability in clinical care, and results in cost efficiencies to benefit all participants in cancer treatment. For more information, visit www.itapartners.com/eviti.

About TrialCheck

TrialCheck is the leading cancer clinical trial search engine created in 2001 by the Coalition of Cancer Cooperative Groups and publicly available at www.CancerTrialsHelp.org. TrialCheck continuously imports information for all cancer clinical studies federally registered with the U.S. Government Department of Health and Human Services via its databases ClinicalTrials.gov, a service of the National Institutes of Health, and Physician Data Query (PDQ®), a cancer database of the National Cancer Institute. Daily quality control processes ensure that the information is accurate and reliable. Using TrialCheck’s unique screening filter, people can obtain tailored information on clinically appropriate, open and enrolling, trials for patients in hospitals, cancer centers and oncology practices across the US and throughout the world.

About ITA Partners

ITA Partners is an independent company with nearly a decade of experience in transforming the quality of oncology care by aligning the interests of patients, physicians and payers to improve clinical outcomes and reduce costs. ITA is committed to ensuring that the best, most appropriate treatment for cancer is prescribed and followed from the start. The company utilizes the expertise of top oncologists and oncology nurses, as well as insurance experts and actuaries, all supported by proprietary technology, to fulfill its mission of providing evidence-based, unbiased support to all parties in the cancer care process. ITA contracts with health plans and other payers, and is not affiliated with any health system, insurance company, pharmaceutical company or provider network. For more information, visit www.itapartners.com.

About the Coalition

The Coalition of Cancer Cooperative Groups is a non-profit service organization working to improve physician and patient access to cancer clinical trials through education, outreach, advocacy and research. Its Board Members are the leaders of the United States’ publicly funded cancer clinical research program. Established in 1997, the Coalition represents the interests of cancer patients and clinical researchers. It promotes the pivotal role of cancer clinical trials in the validation of prevention and treatment advances, works to ensure adequate funding for a robust public cancer clinical trials system that will enable research advances. For more information, visit www.CancerTrialsHelp.org.

###


Contacts: ITA Partners Traci Boehringer 215-569-0656 ext.196	Coalition of Cancer Cooperative Groups Diane Colaizzi 215-789-3612
FOR IMMEDIATE RELEASE
TrialCheck^® - eviti^® Integration Brings Clinical Trials to the Point of Care
Philadelphia, PA [March 3, 2011] –ITA Partners, Inc. (ITA) and the Coalition of Cancer Cooperative Groups (Coalition) today announced that they have reached an agreement in which ITA has acquired ownership of TrialCheck^® – the leading cancer clinical trial search engine – from the Coalition. The TrialCheck database will be merged into ITA’s oncology decision-support platform – eviti^® – which currently contains nearly 1,000 treatment guidelines for 120+ types of cancer; and TrialCheck will remain available to the public via the Coalition website www.CancerTrialsHelp.org through a licensing arrangement. “In our quest to be the most comprehensive oncology decision-support resource, accessible by every oncologist, to treat every cancer patient; we are constantly evolving eviti. This acquisition and integration of the clinical trials database is the ideal next step in providing a holistic approach to oncology treatment options,” said Eduardo Beruff, chief executive officer and president of ITA. As new health care laws will soon require payers to reimburse for clinical trials, the need arises to determine a trial’s appropriateness for each patient. The integration of the TrialCheck database into eviti, not only meets the need, but benefits all parties involved: Patients receive assurance that their physician will identify and suggest appropriate clinical trials as part of their full range of treatment options; Physicians have access to the latest nationally-recognized evidence-based treatment options, including clinical trials that may be beneficial for the patient; Payers are assured that the options presented through eviti, including clinical trials, fit the patient’s diagnosis, and that they are reimbursing for appropriate care. The Coalition and ITA share a common philosophy that physicians, patients and payers should consider clinical trials as a viable treatment option; and integrating the TrialCheck database into eviti brings clinical trial options to the forefront, giving physicians even more treatment options at the point of prescribing. “Strategically, we knew all along that in order to make clinical trials part of the treatment paradigm, a tool as precise as TrialCheck would be most effective when integrated into the normal workflow of the medical practice – where the key interactions among patients, physicians and payers take place.” said Robert L. Comis, MD, president and chairman of the Coalition. “The match with eviti is a perfect fit. While ITA has identified trial searching and protocol navigation as essential components of its product offering, it has not yet developed such a tool. The match repositions TrialCheck to become an integral component of a larger evidence-based prescribing approach.” About eviti eviti is a unique platform that, in real time, aligns physician and payer priorities at the point of care to ensure the most appropriate, evidence-based oncology treatment is administered from the start. ITA’s independent, non-proprietary digital oncology treatment library is one of the most comprehensive of its kind. It comprises nearly 1,000 of the most appropriate, proven treatment options covering all modalities for 120+ cancer types compiled from the world’s leading sources. eviti’s treatment knowledge base and decision-support engine help oncologists select a treatment option that is both evidence-based and compliant with each patient’s insurance plan language at the moment of prescribing. This transparent approach streamlines workflow and reimbursement, reduces variability in clinical care, and results in cost efficiencies to benefit all participants in cancer treatment. For more information, visit www.itapartners.com/eviti. About TrialCheck TrialCheck is the leading cancer clinical trial search engine created in 2001 by the Coalition of Cancer Cooperative Groups and publicly available at www.CancerTrialsHelp.org. TrialCheck continuously imports information for all cancer clinical studies federally registered with the U.S. Government Department of Health and Human Services via its databases ClinicalTrials.gov, a service of the National Institutes of Health, and Physician Data Query (PDQ®), a cancer database of the National Cancer Institute. Daily quality control processes ensure that the information is accurate and reliable. Using TrialCheck’s unique screening filter, people can obtain tailored information on clinically appropriate, open and enrolling, trials for patients in hospitals, cancer centers and oncology practices across the US and throughout the world. About ITA Partners ITA Partners is an independent company with nearly a decade of experience in transforming the quality of oncology care by aligning the interests of patients, physicians and payers to improve clinical outcomes and reduce costs. ITA is committed to ensuring that the best, most appropriate treatment for cancer is prescribed and followed from the start. The company utilizes the expertise of top oncologists and oncology nurses, as well as insurance experts and actuaries, all supported by proprietary technology, to fulfill its mission of providing evidence-based, unbiased support to all parties in the cancer care process. ITA contracts with health plans and other payers, and is not affiliated with any health system, insurance company, pharmaceutical company or provider network. For more information, visit www.itapartners.com. About the Coalition The Coalition of Cancer Cooperative Groups is a non-profit service organization working to improve physician and patient access to cancer clinical trials through education, outreach, advocacy and research. Its Board Members are the leaders of the United States’ publicly funded cancer clinical research program. Established in 1997, the Coalition represents the interests of cancer patients and clinical researchers. It promotes the pivotal role of cancer clinical trials in the validation of prevention and treatment advances, works to ensure adequate funding for a robust public cancer clinical trials system that will enable research advances. For more information, visit www.CancerTrialsHelp.org. ### Coalition of Cancer Cooperative Groups \| 1818 Market Street , Suite 1100, Philadelphia, PA 19103 \| www.CancerTrialsHelp.org ITA Partners \| 1800 JFK Blvd. 9th Floor \| Philadelphia, PA 19103 \| www.itapartners.com